Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-208-1 | CAS number: 6428-31-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
NOAEL oral rat > 2000 mg/kg
NOAEL inhalation rat > 5000 mg/m3
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Firma Charles River Wiga Gmbh Deutschland, Sulzfeld
- Weight at study initiation: The weights of the male rats are: 461,2 g ± 23,3 g. The weights of the female rats are: 275,2 g ± 11 g.
- Fasting period before study: 22 h
- Housing: 3 animals per cage Type 3 Makrolon
- Diet: Altromin 1326 ad libitum
- Water: tap water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20,5 - 22,5
- Humidity (%): 25-40
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12 h light / 12 h dark - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Remarks:
- 600
- Doses:
- Single dose: 2000 mg/kg
- No. of animals per sex per dose:
- 6 male and 6 female
- Control animals:
- yes
- Statistics:
- Not applicable.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- No mortality
- Clinical signs:
- other: Diarrhoea occurred in 3 male rats 5 hours after exposure to the test substance. Discoloration of the faeces occurred 5 day after the exposure.
- Gross pathology:
- No damage to any organs.
- Other findings:
- The exposure to the tested substance did not influencing the behaviour of the animals.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The tested item was found to be non toxic for oral exposure with a LD50 > 2000 mg/kg bw.
- Executive summary:
The acute oral toxicity was assessed following the OECD 401.
The results show no toxicity with a LD value > 2000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, meets generally accepted scientific principles, acceptable for assessment.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Velaz Prague
- Age at study initiation: 8 weeks
- Supplier certification: declared that animals had not the external and internal parasites, pathogenic microorganisms, viruses and fungi.
- Housing: after transporting the animals were placed in polypropylene plastic nursery containers T4 (550 x 320 x 180 mm Velaz Prague), five animals each sex separately.
- Acclimation period: one week
- Diet: fed with granulated mixture ALTROMIN 1320 (Velaz Prague) in a dose of 12 g per animals each day
- Water: drinking water without restrictions
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3°C
- Humidity: 40-60 %
- Photoperiod: 12 hours of light and 12 hours of darkness - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- head only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: samples were dosed by WDFU (Wright Dust Feed Unit MK2, GA 4170, L. Adams, LTD., London) diredtly into an inhalation chamber, where they were dispersed through the spray; the atmosphere inside the inhalation chamber was homogeneous.
- Method of holding animals in test chamber: animals were fixed in a glass tube of diameter 60 mm so that the face of the glass cylinder to interfere with the vertical axis - 250 mm in diameter- in which there was a linear dynamic atmosphere exchange at 8 l/min.
- Source and rate of air: compressed air was taken from the central distribution Synthesia. Air flow was measured continuously throughout the exposure.
TEST CONDITIONS
- The average air flow apparatus: 0.480 m3/h
- The temperature inside the apparatus: 24°C
- Relative humidity inside the apparatus: 45%
- Actual concentration: 4.91 mg/L air
TEST SUBSTANCE
- Particle size of the test substance: :
diameter 1-4: 364.8 ± 5.86 (89.04 %);
diameter 4-10: 35.3 ± 2.48 (8,62 %);
diameter 10-20: 8.2 ± 0,64 (2.00 %);
diameter >20: 1,4 ± 0.34 (0.34 %) - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- ca. 4 h
- Concentrations:
- 4.91 mg/l air
- No. of animals per sex per dose:
- 5 males and 5 non-pregnant females.
- Control animals:
- yes
- Details on study design:
- - Immediately after application the animals were removed from tube, placed in breeding containers and observed.
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: before exposure and after 7 and 14 day
- Other examinations performed: clinical diagnosis was focused on the observation of nutritional status (food intake and water), the appearance of hair and skin, visible mucous membranes, mental activity, somatomotor activity, response to stimuli, focusing on sensitization and reactivity, lacrimation, functional assessment of the respiratory, circulatory, digestive and urogenital apparatus.
- After 14 days the animals were killed and an autopsy was performed. At autopsy were examined macroscopically thoracic and abdominal organs and lungs, trachea, larynx, thymus, liver, spleen and kidneys. - Statistics:
- No data
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- ca. 5 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- During the test and during the observation period (14 days) there was no mortality of the tested animals.
- Clinical signs:
- other:
- Body weight:
- The increase of body weight of animals tested was in according to the trend of increase of control animals.
- Gross pathology:
- Immediately thereafter after the 14-day observation period the animals were killed . After an autopsy was performed, focusing on the overall examination of the body surface and orifices, and macroscopic examination of the thoracic, abdominal and selected organs - trachea, lungs, heart, thymus, liver, spleen and kidneys.
In one male was present a diffuse pulmonary congestion.
In females were observed different effect:
- Female 1: numerous punctate hemorrhages on the right lung. No other pathological anatomical findings.
- Female 2: No pathological anatomical findings.
- Female 3: sharply defined deposits a small pea size founded in the right lung. In the left lung were observed edema.
- Female 4: grey-blue sharply defined deposits with size from pinehead to pea were observed in both lungs.
- Female 5: Similar findings has been identified as female 4. - Other findings:
- Potential target organs: Trachea , lungs, heart,thymus, liver, spleen and kidneys.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- A sample of Direct Black 19 were tested for limit test for acute inhalation toxicity. During the exposure or during the 14-day observation period there was no death of animals tested.
The results showed some effects that could be considered as a result of the strong irritating effects of the tested substance. - Executive summary:
- Direct Black 19 was tested for acute inhalation toxicity. During exposure and during the 14-day observation period there was no mortality of experimental animals.
The effects observed during the expsoure, black fluid from eyes and nasal cavity, and after the macroscopic examination, pathological changes in the lungs (pulmonary congestion, haemorrhages in the lungs, pulmonary edema and major lobular pneumonia) can be considered as a result of strong irritating effect of the tested substances on exposed mucous upper and lower respiratory tract.
Given that these pathological changes observed in the lungs, predominantly in females (one male was found only pulmonary congestion, other males were no pathological changes), it can be considered an increasing of the sensitivity of the female sex.
Reference
Observations during the exposure:
Immediately after application the animals were removed from tubes, placed in breeding containers and observed.
- 60 min after application:
animals presented the same symptoms of intoxication of the first observation
- 120 min after application:
animals presented the same symptoms of previous observations
- 2 days after application:
stains of the test-compound on the hair, and brown-black colored (color of dark beer) urine of all of testing animals was observed. No other clinically detectable health disorders.
- From 3 to 4 days after application:
animals presented the same symptoms of previous days
- From 5 to 14 days after application: during this period there were no clinical signs of intoxication.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 5 000 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
No Adverse Effect level for acute toxicity oral is LD50 > 2000 mg/kg.
No Adverse Effect level for acute toxicity inhalation is LD50 > 5000 mg/m3.
Justification for classification or non-classification
According to the CLP Regulation (EC n. 1272/2008), 3.1 Acute toxicity section, substances can be allocated to one offour toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
The oral LD50 value was established to be more than 2000 mg/kg body weight and the LD50 for inhlataion is > 5000 mg/kg bw therefore the test substance is out of any classification limit for acute oral toxicity (oral acute toxicity.
No classification for acute toxicity is warranted under Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.